Algae-Based Medical Adhesives Developer Sealantis Sold for $25 Million

(Calcalist) Lilach Baumer - UK-headquartered Advanced Medical Solutions has acquired Israel-based medical adhesives developer Sealantis Ltd. for $25 million, the two announced Thursday. Hailing from Israel's Technion-Israel Institute of Technology, Sealantis uses an algae-based polymer with no proteins to develop medical adhesives with reduced risks of infection or allergic reaction. Surgical glue, often used in place of sutures or staples, has benefits such as less scarring and less time in the operating room, but some people react negatively to its components.


2019-02-01 00:00:00

Full Article

BACK

Visit the Daily Alert Archive